Atlas Trials

In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure

Clinical trial NCT02590627 · COMPLETED

Trial details

NCT number
NCT02590627
Sponsor
National Institute for Medical Research, Tanzania
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Malaria
Start date
2014-05-01
Primary completion
2015-12-01
Enrollment
509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.